2016 American Transplant Congress

June 11-15, 2016 in Boston, MA

View by Title View Sessions

View by Date

Saturday, June 11, 2016

5:30pm-7:30pm: Pre-Transplant Intra-Arterial Liver Directed Therapy Does Not Increase the Risk of Hepatic Arterial Misadventures in Liver Transplantation.

J. Kallini,² A. Gabr,² R. Salem,² R. Lewandowski,² T. Baker.¹

Poster Session A: Liver - Hepatocellular Carcinoma and Cholangiocarcinoma Malignancies • Halls C&D

5:30pm-7:30pm: Predicting Late Medication Non-Adherence in Adult Kidney Transplant Recipients.

D. Taber, A. Posadas, A. Chokkalingam, R. Browning, N. Salazar, M. Kamel, R. Pullalarevu, B. Kadri, K. Chavin, T. Srinivas, P. Baliga.

Poster Session A: Long Term Outcomes in Kidney Transplantation • Halls C&D

5:30pm-7:30pm: Predictive Value of Preoperation Serum Gamma-Glutamyltranspeptidase for Hepatocellular Carcinoma Prognosis After Liver Transplantation.

S. Fu, Q. Zhao, M. Chen, L. Wu, Q. Ren, F. Ji, Z. Guo, X. He.

Poster Session A: Liver - Hepatocellular Carcinoma and Cholangiocarcinoma Malignancies • Halls C&D

5:30pm-7:30pm: Predictors of Outcomes After Kidney Transplantation in the Setting of Chronic Opiate Use.

R. Evans,¹ N. Neville,² A. Fugit,³ R. Gedaly,¹ T. Clifford.¹

Poster Session A: Poster Session III: Kidney Complications-Other • Halls C&D

5:30pm-7:30pm: Pretransplant Serum Hyaluronic Acid Can Be a Prognostic Predictor in Adult-to-Adult Living Donor Liver Transplantation.

S. Mizuno,¹ B. Das,² Y. Iizawa,¹ H. Kato,¹ Y. Murata,¹ A. Tanemura,¹ N. Kriyama,¹ Y. Azumi,¹ M. Kishiwada,¹ M. Usui,¹ H. Sakurai,¹ S. Isaji.¹

Poster Session A: Living Donor Liver Transplantation • Halls C&D

5:30pm-7:30pm: Prospective Long-Term Analysis of B- and Plasma Cell Subsets in Renal Transplant Patients After Combined Treatment with Rituximab and Bortezomib in Antibody Mediated Rejection.

M. Duerr, F. Halleck, O. Staeck, L. Lehner, D. Khadzhynov, S. Eva, J. Waiser, K. Budde.

Poster Session A: B cells & AMR, Alloreactivity, Immune Regulation & Regulatory T Cells, T Cell Biology and Alloreactivity, Immunesuppression • Halls C&D

5:30pm-7:30pm: Quality of Postoperative Pain Care in Living Liver Donors.

M. Mandell,¹ A. Smith,^2,6 D. Gordon,³ S. Holtzman,⁴ M. Dew,⁵ T. Howell,⁶ A. DiMartini,⁵ Z. Butt,⁸ M. Simpson,⁷ C. Freise,⁹ S. McCluskey,¹⁰ R. Fisher,¹¹ J. Guaerra,¹² K. Olthoff,¹³ E. Pomfret.⁷

Poster Session A: Living Donor Liver Transplantation • Halls C&D

5:30pm-7:30pm: Radiosensitive Cell Population Prolongs Graft Survival of Vascularized Composite Allografts in Non-Human Primates.

M. Uluer, J. Woodall, W. Hassanein, U. Drhu, B. Bojovic, A. Nam, S. Bartlett, R. Barth.

Poster Session A: Clinical Vascularized Composite Allotransplantation • Halls C&D

5:30pm-7:30pm: Rapamycin (RPM) Synergizes with CD154 mAb and DST to Promote Long-Term Vascularized Composite Allograft (VCA) Survival, but Prevents Induction of Donor-Specific Tolerance.

L. Wang, Z. Wang, R. Han, T. Bhatti, L. Levin, M. Levine, W. Hancock.

Poster Session A: Clinical Vascularized Composite Allotransplantation • Halls C&D

5:30pm-7:30pm: Rapid Emergence of CD28^null Cells Following Ex Vivo Restimulation Is Associated with Belatacept Resistant Rejection.

M. Cortes, S. Laurie, B. Sayed, M. Ford.

Poster Session A: Kidney: Acute Cellular Rejection • Halls C&D